Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jun 28, 2014; 20(24): 7794-7800
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7794
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7794
Ref. | Design | No | Target | Composite | Administration | CLE system |
Hsiung et al[11] | In vivo | 26 | Colorectal adenomas | Fluorescein-labelled septapeptides | Topical | Probe-based |
Foersch et al[18] | Animal, and ex vivo | 25 and 14 | CRC | Alexa-Fluor 488-labelled VEGF-antibodies | Intravenous and topical | Endoscope-based |
Goetz et al[10] | Animal and ex vivo | 68 and 16 | CRC | FITC-labelled anti-EGFR-antibodies | Intravenous and topical | Endoscope-based |
Foersch et al[37] | Animal and ex vivo | 12 and 4 | CRC | Alexa-Fluor 488-labelled bevacizumab | Intravenous and topical | Endoscope-based |
Liu et al[23] | In vivo | 37 | CRC and adenomas | Alexa-Fluor 488-labelled anti-EGFR-antibodies | Topical | Endoscope-based |
Cârţână et al[27] | Ex vivo | 4 | CRC | Alexa-Fluor 488-labelled anti-CD31-antibodies | Topical | Endoscope-based |
Nakai et al[19] | Animal | 2 | Healthy esophageal and gastric mucosa | Fluorescein conjugated anti-EGFR-antibodies and anti-survivin-antibodies | Submucosal or topical | Probe-based |
Hoetker et al[32] | Animal | 26 | Gastric cancer | FITC-labelled anti-EGFR1-antibodies or Alexa-Fluor 488-labelled cetuximab | Intravenous | Endoscope-based |
Nakai et al[20] | Animal | 2 | Healthy pancreas | FITC-labelled anti-EGFR1-antibodies or Alexa-Fluor 488-labelled cetuximab | Intravital | Needle-based |
Atreya et al[34] | In vivo | 25 | Colonic mucosa in Crohn’s disease | FITC-labelled adalimumab | Topical | Endoscope-based |
Neumann et al[26] | Ex vivo | 2 | Colonic mucosa in Clostridium difficile associated colitis | Fluorescein-labelled Clostridium difficile specific probe | Topical | Endoscope-based |
Li et al[22] | Animal and ex vivo | 20 and 23 | Gastric cancer | Alexa-Fluor 488-labelled anti-MG7-Ag-antibodies | Intracardial and topical | Endoscope-based |
Goetz et al[33] | Animal | 44 | CRC | FITC-labelled anti-EGFR-antibodies or Alexa-Fluor 488-labelled cetuximab | Intravenous | Endoscope-based |
Neumann et al[25] | Ex vivo | N/A | Barrett’s esophagus | FITC-labelled Muc2-antibodies | Topical | N/A |
Sturm et al[12] | In vivo | 25 | Barrett’s esophagus | FITC-labelled peptides | Topical | Probe-based |
-
Citation: Karstensen JG, Klausen PH, Saftoiu A, Vilmann P. Molecular confocal laser endomicroscopy: A novel technique for
in vivo cellular characterization of gastrointestinal lesions. World J Gastroenterol 2014; 20(24): 7794-7800 - URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7794.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7794